Susan Chi
Impact in
Papers in
- Genetics 59
- Glioma Diagnosis and Treatment 58
-
- Chromatin Remodeling and Cancer 24
- Protein Degradation and Inhibitors 7
- Co-authors
- Mark W. Kieran (37 shared papers)Liliana Goumnerova (21 shared papers)Nicole J. Ullrich (19 shared papers)Karen J. Marcus (16 shared papers)Peter Manley (15 shared papers)Jaclyn A. Biegel (4 shared papers)Mary Ann Zimmerman (11 shared papers)Franck Bourdeaut (6 shared papers)
- Journals
- Neuro-Oncology (31 papers)Journal of Clinical Oncology (16 papers)Pediatric Blood & Cancer (15 papers)Journal of Neuro-Oncology (14 papers)Cancer Medicine (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Susan Chi
119 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 111
- Genetics 1.6k
- Neurology 925
- Pathology and Forensic Medicine 437
- Molecular Biology 1.6k
- Cancer Research 266
Countries citing papers authored by Susan Chi
This map shows the geographic impact of Susan Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Chi more than expected).
Fields of papers citing papers by Susan Chi
This network shows the impact of papers produced by Susan Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Chi. The network helps show where Susan Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 336 | |
| 2 | 2011 | 229 | |
| 3 | 2014 | 201 | |
| 4 | 2005 | 169 | |
| 5 | 2010 | 165 | |
| 6 | 2016 | 158 | |
| 7 | 2004 | 147 | |
| 8 | 2017 | 126 | |
| 9 | 1993 | 125 | |
| 10 | 2013 | 110 | |
| 11 | 2016 | 86 | |
| 12 | 2006 | 81 | |
| 13 | 1998 | 81 | |
| 14 | 2019 | 72 | |
| 15 | Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. | 2001 | 70 |
| 16 | 2005 | 67 | |
| 17 | 2017 | 67 | |
| 18 | 2012 | 62 | |
| 19 | 2015 | 62 | |
| 20 | 2006 | 60 |
About Susan Chi
Susan Chi is a scholar working on Genetics, Molecular Biology, Neurology, Pulmonary and Respiratory Medicine and Oncology, having authored 130 papers that have together received 3.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (58 papers), Neuroblastoma Research and Treatments (24 papers), Chromatin Remodeling and Cancer (24 papers), Cancer Mechanisms and Therapy (12 papers), Brain Metastases and Treatment (9 papers), Sarcoma Diagnosis and Treatment (7 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Genetics (1.6k citations), Neurology (925 citations), Pathology and Forensic Medicine (437 citations), Molecular Biology (1.6k citations) and Cancer Research (266 citations). Susan Chi has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Mark W. Kieran, Liliana Goumnerova, Nicole J. Ullrich, Karen J. Marcus, Peter Manley, Jaclyn A. Biegel, Mary Ann Zimmerman, Franck Bourdeaut, Christine Chordas and Charles W.M. Roberts. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Pediatric Blood & Cancer, Journal of Neuro-Oncology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.